Subscribe to Newsletter

Formulation

Manufacture Business Practice

Assessing the effect of formulation composition on spidroin charge and stability

Work performed in conjunction with Spiber Technologies, Uppsala, Sweden. Use of dynamic and electrophoretic light scattering to assess the effects of protein formulation composition

Discovery & Development Drug Delivery

Micro-Formulating for Dermal Drug Delivery

| Sponsored by BASF

Industry is beginning to appreciate how formulation microstructure makes a fundamental contribution to dermal drug delivery – and this new understanding emphasizes the key role of excipients.

Discovery & Development Drug Delivery

Insolubility Insight

Solubility is a key for drug delivery but pipelines are full of compounds with poor solubility.

Business & Regulation Formulation

Lean, Mean Stability Machine

The stability of drug formulations is essential. But what should be monitored – and how often?

Discovery & Development Drug Delivery

A Future of Printing Powders?

3D printing is starting to sound attractive - but we really need to understand our powders.

Discovery & Development Business Practice

Design and formulation of nanomedicines

In this white paper the specific mechanisms by which nanoparticles are designed and formulated for therapeutic purposes and in which NTA has had a significant part to play is discussed.

Discovery & Development Biosimilars

Taylor Dispersion Analysis explained

Taylor Dispersion Analysis is an ultra-low volume, microcapillary flow technique for sizing and stability of biomolecules in complex solutions, and offers advantages for orthogonal and complementary biophysical characterization measurements.

Discovery & Development Business Practice

Accelerate liquid formulation development for protein biopharmaceuticals

The work presented here illustrates how Differential Scanning Calorimetry (DSC) is used in the early stages of protein characterization to rapidly provide critical data about protein stability that can be used as a guide to support and accelerate liquid formulation.

Discovery & Development Business Practice

Reverse engineering of a pharmaceutical formulation

The Morphologi G3-ID can be used to generate component-specific particle size and shape data required to aid the reverse engineering of solid oral dose formulations. Here, we provide an example case study for a powder formulation.

Discovery & Development Drug Delivery

From Brick Dust to Blockbuster?

| Sponsored by BASF

Many drug candidates are as poorly soluble as “brick dust”, making oral delivery a significant challenge.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register